![Kimberly Blackwell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kimberly Blackwell
Directeur/Membre du Conseil chez
MONTE ROSA THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Kimberly L.
Blackwell is the founder of Cereius, Inc., established in 2017, serving as President.
Current jobs include Director at Fore Biotherapeutics, Inc. since 2021, Independent Director at Century Therapeutics, Inc. since 2021, and Independent Director at Monte Rosa Therapeutics, Inc. since 2020.
Former jobs include Director at Neoantigenics, Inc., Director-Women's Cancer Program & Professor at Duke Cancer Institute from 1997 to 2018, Director at Century Therapeutics, Inc. in 2021, Director, Chief Executive & Medical Officer at Zentalis Pharmaceuticals, Inc. from 2020 to 2024, VP-Early Phase Oncology & Immuno-Oncology at Eli Lilly & Co. from 2018 to 2020, Professor at Duke University from 1997 to 2018, Vice President-Early Phase Oncology at Lilly Oncology, and Chief Medical Officer & SVP-Clinical Oncology at Tempus AI, Inc. from 2020 to 2022.
Education includes undergraduate degree from Duke University and doctorate from Mayo Clinic College of Medicine & Science.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 11/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Kimberly Blackwell
| Sociétés | Poste | Début |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2020 |
| CENTURY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2021 |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Directeur/Membre du Conseil | 20/09/2021 |
Cereius, Inc.
 Cereius, Inc. BiotechnologyHealth Technology Develops novel radio-labeled therapeutics for treating solid tumor brain metastasis | Fondateur | 01/01/2017 |
Anciens postes connus de Kimberly Blackwell
| Sociétés | Poste | Fin |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Directeur Général | 13/11/2024 |
| TEMPUS AI, INC. | Directeur Technique/Scientifique/R&D | 16/05/2022 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/03/2020 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2018 |
Duke Cancer Institute
 Duke Cancer Institute Hospital/Nursing ManagementHealth Services Operates cancer center | Corporate Officer/Principal | 01/01/2018 |
Formation de Kimberly Blackwell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
98
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Neoantigenics, Inc.
 Neoantigenics, Inc. Medical SpecialtiesHealth Technology Developes therapeutic plus diagnostic products | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Mayo Clinic College of Medicine & Science
 Mayo Clinic College of Medicine & Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Health Technology |
Tempus AI, Inc.
 Tempus AI, Inc. Packaged SoftwareTechnology Services Develops clinical & molecular data platform for healthcare | Technology Services |
Duke Cancer Institute
Duke Cancer Institute Hospital/Nursing ManagementHealth Services Operates cancer center | Health Services |
Cereius, Inc.
Cereius, Inc. BiotechnologyHealth Technology Develops novel radio-labeled therapeutics for treating solid tumor brain metastasis | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
Century Therapeutics, Inc. /Old/
 Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
